Re. Hintze et al., Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors, GASTROIN EN, 53(1), 2001, pp. 40-46
Background: Advanced and incurable Klatskin tumors of Bismuth-type III and
IV cause obstructive jaundice. Palliation of patients with Klatskin tumors
is usually carried out by bilateral endoscopic stent placement. Endoscopic
retrograde cholangiography (ERC) in such patients is associated with a comp
aratively high morbidity and mortality mainly due to postprocedure bacteria
l cholangitis. To reduce ERC-related complications the outcome of replacing
ERC with magnetic resonance cholangiopancreatography (MRCP) was investigat
ed. Subsequently, unilateral contrast injection and stent placement were pe
rformed, thus avoiding bilateral contrast injection and stent insertion.
Methods: Patients thought to have a Klatskin tumor underwent clinical evalu
ation, laboratory, and noninvasive imaging studies before ERC. Patients wer
e enrolled in this feasibility study if investigators agreed with the clini
cal diagnosis of an advanced and incurable Klatskin tumor. MRCP images were
used to determine the predominate ductal drainage for the liver segments t
hus directing stent placement. Based on these findings, unilateral ERC and
subsequent unilateral stent placement were performed. Antibiotics were not
given before ERC. Amsterdam-type stents (10F) were placed and replaced rout
inely at 2 months. In cases of earlier occlusion, the stents were replaced
immediately.
Results: Thirty-five patients underwent MRCP, ERC, and unilateral stent dep
loyment. Two further patients enrolled after MRCP were withdrawn because ER
C could not be carried out. In 35 patients with unilateral stents bilirubin
levels decreased (18.9 +/- 6.3 mg/dL to 3.2 +/- 2.3 mg/dL) and jaundice re
solved in 86%. After first stent deployment, post-ERC bacterial cholangitis
occurred in 6% (2 of 35) of patients.
Conclusions: This new method of MRCP-guided endoscopic unilateral stent pla
cement could reduce ERC-related complications caused by initial stent deplo
yment. The results of this study justify a randomized prospective comparati
ve trial.